Re-optimization of Shanghai Fudan criteria for liver transplantation based on different origins of multinodular hepatocellular carcinoma and its preliminary mechanism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053585

Enrollment

Unknown

Registered

2021-11-24

Start date

2022-11-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Liver Cancer

Interventions

polycentric origin group:MRI scanning

intrahepatic metastasis group:MRI scanning

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Cases of liver cancer who received liver transplantation; 2. Multi-nodular liver cancer (>= 2 nodules); 3. Perform multimodal MRI examination in our hospital within 14 days before receiving liver transplantation.

Exclusion criteria

Exclusion criteria: 1. Unqualified MRI image quality; 2. The MRI scan sequence is incomplete; 3. Other treatments before liver transplantation, including liver resection, TACE, ablation, etc.; 4. Lack of postoperative pathological data or genetic test results; 5. Postoperative pathology or gene sequencing cannot confirm IM or MO type.

Design outcomes

Primary

Measure	Time frame
Similarity between nodules;	—

Countries

China

Contacts

Public ContactZeng Mengsu

Zhongshan Hospital, Fudan University

zeng.mengsu@zs_hospital.sh.cn+86 13501922963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026